Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Transcatheter Mitral Valve Replacement Market: By Product Type, By Application, By End User, and Geography
Transcatheter Mitral Valve Replacement Market size was valued at US$ 1,025.3 million in 2023 and is poised to grow at a significant CAGR of 6.7% over 2024-2030. The most common anomaly in the world is mitral regurgitation, and the frequency of the condition is rising in the elderly population. According to research by the National Center for Biotechnology Information (NCBI), there are currently 1.3 million adult sufferers of mitral regurgitation in the United States. The need for transcatheter mitral valves is being driven by transcatheter mitral valve replacement (TMVR), which has become a therapeutic alternative for the treatment of mitral regurgitation in patients at high or prohibitive surgical risk.
Furthermore, the prevalence of degenerative primary mitral regurgitation and ischemia functional secondary mitral regurgitation is driving the rising demand for transcatheter mitral valves. Transcatheter aortic valve replacement (TAVR) has been approved for patients of all risk groups due to developments in transcatheter technologies that have revolutionized how aortic valve disease is treated. Increased frequency of mitral valve disease among the elderly population is another effect of rising life expectancy in developed nations.
However, due to anatomical limitations or higher surgical risks, traditional therapeutic techniques may not be appropriate for older persons. Medical researchers and the transcatheter medicines sector are proliferating to create a new transcatheter method for mitral valve replacement. Due to transcatheter treatment's less intrusive nature, common risks associated with surgery can also be avoided, allowing for symptomatic alleviation without increasing early perioperative risk. Most patients with symptomatic severe mitral regurgitation are not candidates for conventional surgery because of their high-risk factors and the lack of data demonstrating how a procedure affects challenging outcomes.
Additionally, the market is anticipated to grow in the upcoming years due to technical developments and the release of new mitral valves. Additionally, it is expected that the market will be driven by the growing elderly population and the rising need for more minor invasive procedures for high-risk patients during the estimated period. New market prospects are presented by increased healthcare spending and the advent of cardiovascular illnesses in developing nations.
Transcatheter Mitral Valve Replacement Market Recent Key Developments
Study Period
2024-2030Base Year
2023CAGR
N/ALargest Market
North-AmericaFastest Growing Market
North-America
The rising number of people addicted to smoking is expected to impact the transcatheter mitral valve replacement market's growth. Dysphagia is one of the most dangerous side effects of smoking cigarettes for a lengthy period. While tobacco usage kills nearly 6 million people each year, the rising prevalence of oropharyngeal cancer drives the dysphagia market forward. The market's expansion is projected to be restrained by the side effects and pain of dysphagia medications and tubes. Long-term use of dysphagia medicines like proton pump inhibitors is linked to a higher risk of hip fracture due to decreased calcium and iron absorption, as well as an increased risk of opportunistic infections with S. pneumoniae and C. difficult due to weakened natural gut flora.
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Global Transcatheter Mitral Valve Replacement Market Introduction |
2.1. Global Transcatheter Mitral Valve Replacement Market – Taxonomy |
2.2. Global Transcatheter Mitral Valve Replacement Market –Definitions |
2.2.1. Product Type |
2.2.2. Application |
2.2.3. End User |
2.2.4. Region |
3. Global Transcatheter Mitral Valve Replacement Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Transcatheter Mitral Valve Replacement Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID 19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic |
3.8. Mapping Market Players Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations and Mergers |
4. Global Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Transcatheter Mitral Valve Replacement Market Forecast, By Product Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1. Transcatheter Mitral Valve Replacement |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Transcatheter Mitral Valve Repair |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Transcatheter Mitral Valve Replacement Market Forecast, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1. Mitral Stenosis |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Mitral Regurgitation |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Mitral Valve Prolapse |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Transcatheter Mitral Valve Replacement Market Forecast, By End User, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cardiac Catheterization Laboratories |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Transcatheter Mitral Valve Replacement Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2022 - 2028 |
9. North America Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Transcatheter Mitral Valve Replacement |
9.1.2. Transcatheter Mitral Valve Repair |
9.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Mitral Stenosis |
9.2.2. Mitral Regurgitation |
9.2.3. Mitral Valve Prolapse |
9.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Ambulatory Surgical Centers |
9.3.3. Cardiac Catheterization Laboratories |
9.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. U.S. |
9.4.2. Canada |
9.5. North America Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 - 2028 |
9.6. North America Transcatheter Mitral Valve Replacement Market Dynamics – Trends |
10. Europe Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
10.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Transcatheter Mitral Valve Replacement |
10.1.2. Transcatheter Mitral Valve Repair |
10.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Mitral Stenosis |
10.2.2. Mitral Regurgitation |
10.2.3. Mitral Valve Prolapse |
10.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Ambulatory Surgical Centers |
10.3.3. Cardiac Catheterization Laboratories |
10.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Italy |
10.4.5. Spain |
10.4.6. Rest of Europe |
10.5. Europe Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 - 2028 |
10.6. Europe Transcatheter Mitral Valve Replacement Market Dynamics – Trends |
11. Asia-Pacific Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
11.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Transcatheter Mitral Valve Replacement |
11.1.2. Transcatheter Mitral Valve Repair |
11.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Mitral Stenosis |
11.2.2. Mitral Regurgitation |
11.2.3. Mitral Valve Prolapse |
11.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Ambulatory Surgical Centers |
11.3.3. Cardiac Catheterization Laboratories |
11.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Rest of Asia-Pacific |
11.5. Asia-Pacific Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 - 2028 |
11.6. Asia-Pacific Transcatheter Mitral Valve Replacement Market Dynamics – Trends |
12. Latin America Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
12.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Transcatheter Mitral Valve Replacement |
12.1.2. Transcatheter Mitral Valve Repair |
12.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Mitral Stenosis |
12.2.2. Mitral Regurgitation |
12.2.3. Mitral Valve Prolapse |
12.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Ambulatory Surgical Centers |
12.3.3. Cardiac Catheterization Laboratories |
12.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Argentina |
12.4.3. Rest of Latin America |
12.5. Latin America Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 - 2028 |
12.6. Latin America Transcatheter Mitral Valve Replacement Market Dynamics – Trends |
13. Middle East and Africa Transcatheter Mitral Valve Replacement Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
13.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Transcatheter Mitral Valve Replacement |
13.1.2. Transcatheter Mitral Valve Repair |
13.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Mitral Stenosis |
13.2.2. Mitral Regurgitation |
13.2.3. Mitral Valve Prolapse |
13.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Hospitals |
13.3.2. Ambulatory Surgical Centers |
13.3.3. Cardiac Catheterization Laboratories |
13.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Saudi Arabia |
13.4.2. GCC Countries |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Transcatheter Mitral Valve Replacement Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 - 2028 |
13.6. MEA Transcatheter Mitral Valve Replacement Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Abbott Laboratories |
14.2.2. Edward Lifesciences |
14.2.3. HLT Medical |
14.2.4. LivaNova Plc |
14.2.5. Medtronic Plc |
14.2.6. Neovasc Inc. |
14.2.7. NeoChord |
14.2.8. Venus Medtech |
14.2.9. MValve Technologies |
14.2.10. Innoveheart SRL |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players